Path: ...!npeer.as286.net!npeer-ng0.as286.net!feeder1-1.proxad.net!proxad.net!feeder1-2.proxad.net!cleanfeed1-b.proxad.net!nnrp2-2.free.fr!not-for-mail
Date: Wed, 17 Jan 2024 19:14:10 +0100
MIME-Version: 1.0
User-Agent: Mozilla Thunderbird
Subject: =?UTF-8?Q?Re=3A_ARN=2C_antibiotiques_=3A_les_r=C3=A9v=C3=A9lations_?=
 =?UTF-8?Q?exclusives_du_professeur_Raoult_!?=
Newsgroups: fr.misc.actualite.covid19
References: <65a58b97$0$2566$426a74cc@news.free.fr>
 <uo43nm$12egg$1@dont-email.me> <65a59a57$0$16352$426a74cc@news.free.fr>
 <iLe6LmBnovK21a3H5b835jFlC4A@jntp> <65a673ff$0$7524$426a74cc@news.free.fr>
 <N8agOErrczBDmWylw7WYW2397wc@jntp> <65a676ad$0$7524$426a74cc@news.free.fr>
 <7lA7UGyoFgAfKZHcL7WTqBZqHNQ@jntp> <65a678e7$0$2999$426a74cc@news.free.fr>
 <DNDHE758hwLglvf7vm06lSl8mH4@jntp> <65a6e649$0$8252$426a74cc@news.free.fr>
 <uo83mq$1tv46$1@dont-email.me>
Content-Language: fr
From: =?UTF-8?Q?Le_tr=C3=A8s_gentil_Luciole135?= <luciole135@invalid.free.fr>
In-Reply-To: <uo83mq$1tv46$1@dont-email.me>
Content-Type: text/plain; charset=UTF-8; format=flowed
Content-Transfer-Encoding: 8bit
Lines: 19
Message-ID: <65a818f2$0$29758$426a74cc@news.free.fr>
Organization: Guest of ProXad - France
NNTP-Posting-Date: 17 Jan 2024 19:14:10 CET
NNTP-Posting-Host: 78.192.128.96
X-Trace: 1705515250 news-3.free.fr 29758 78.192.128.96:62411
X-Complaints-To: abuse@proxad.net
Bytes: 2566

Le 17/01/2024 à 9:38, bruno a écrit :
> We searched Pubmed, from 1st December 2019, to 15th March 2021, using 
> the keywords "coronavirus", "severe acute respiratory syndrome 2 
> coronavirus", "SARS-CoV-2", "novel coronavirus", "nCoV", "2019-nCoV" and 
> "COVID-19" and "cohort". From Pubmed, we selected studies according to 
> the following inclusion criteria: multicentre study, study size ≥ 500 
> patients to avoid centre effect, study reporting the treatments used in 
> COVID-19 and the number of patients treated with these drugs. Studies 
> including only patients receiving HCQ, receiving HCQ from August 2020 
> onwards, and patients already treated with HCQ for autoimmune conditions 
> were excluded, as well as studies from countries for which mortality 
> data were lacking.

Qu'est-ce que vous ne comprenez pas dans le fait que cette projection, 
puisqu'il s'agit d'une projection et non pas d'une étude 
observationnelle ait sélectionné 44 études sur 7748, ce qui la rend non 
significative.
Sachant de plus qu'une projection ne peut pas par essence signifier quoi 
que ce soit.